The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $35,763,891 in first-year total cost, median $5,849,947.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OBT-C (50)]5
Most frequent institutions
- DUKE UNIVERSITY1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- ROCKEFELLER UNIVERSITY1
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL1
- UT SOUTHWESTERN MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Targeting EWSR1-FLI1 through Functional, Structural and Chemical Approaches1U54CA231649-01A1 | AMATRUDA, JAMES FMCFADDEN, DAVID GLENN | UT SOUTHWESTERN MEDICAL CENTER, TX | $10,042,149 | ZRG1 |
| 2019 | Experimental and preclinical modeling of NUP98-rearranged acute leukemia1U54CA243124-01 | MULLIGHAN, CHARLES G. | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $9,965,625 | ZRG1 |
| 2019 | Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma1U54CA231630-01A1 | COUNTER, CHRISTOPHER MLINARDIC, CORINNE MARY | DUKE UNIVERSITY, NC | $5,849,947 | ZRG1 |
| 2019 | Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma1U54CA243126-01 | SIMON, SANFORD M | ROCKEFELLER UNIVERSITY, NY | $5,000,000 | ZRG1 |
| 2019 | Biology and therapy of C11orf95-RELA fusion-driven ependymoma1U54CA243125-01 | HOLLAND, ERIC C. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $4,906,170 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.